Skip to main content

Table 1 Clinical characteristics of the subjects

From: Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

 

Diabetes with CAD

Diabetes without CAD

Age (years)

59.2 ± 7.9

58.3 ± 9.9

Sex (number, male/female)

11/4

10/5

Body mass index (kg/m2)

24.3 ± 1.2

23.1 ± 1.5

AGE-p (U/ml)

6.3 ± 1.5

5.1 ± 0.9*

Systolic blood pressure (mmHg)

130.2 ± 16.2

133.2 ± 22.1

Diastolic blood pressure (mmHg)

81.2 ± 13.2

85.2 ± 10.2

Total cholesterol (mmol/l)

4.22 ± 0.54

4.56 ± 0.26

HDL cholesterol (mmol/l)

1.08 ± 0.27

0.98 ± 0.19

Triglycerides (mmol/l)

1.96 ± 0.41

2.01 ± 0.19

Fasting glucose(mmol/l)

6.48 ± 0.7

6.2 ± 0.3

HbA 1c (%)

6.4 ± 0.76

6.7 ± 0.26

Serum creatinine (μmol/l)

68.2 ± 17.9

71.2 ± 14.8

Microalbuminuria/urine creatinin

42.3 ± 4.5

35.6 ± 9.2

  1. *P < 0.05 compared with diabetes with CAD
  2. AGE-p advanced glycation end products-peptides, HDL high-density lipoprotein, CAD coronary artery atherosclerosis